| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/22/2004 | DE10228627A1 Verfahren zur Prophylaxe und Therapie von Mykosen bei Fischen und Wirbellosen und deren Entwicklungsstadien Method for the prophylaxis and treatment of mycoses in fish and invertebrates and their stages of development |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | CA2492743A1 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492554A1 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 01/22/2004 | CA2492373A1 Cephalosporins |
| 01/22/2004 | CA2492194A1 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites |
| 01/22/2004 | CA2492164A1 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | CA2492068A1 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | CA2492045A1 Substituted amine derivatives and methods of use |
| 01/22/2004 | CA2491183A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/22/2004 | CA2491080A1 Use of aspartic proteases in cosmetics and therapeutics |
| 01/22/2004 | CA2490666A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/21/2004 | EP1382608A1 Sulfate of cephem compound |
| 01/21/2004 | EP1382605A2 8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands |
| 01/21/2004 | EP1382603A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF |
| 01/21/2004 | EP1382348A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/21/2004 | EP1382344A1 Bactericidal disinfectant, antibacterial drug, and antibacterial material |
| 01/21/2004 | EP1382343A1 Combination therapy to treat hepatitis B virus |
| 01/21/2004 | EP1382335A1 Medicines |
| 01/21/2004 | EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381681A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/21/2004 | EP1381674A2 Method for generating highly active human dendritic cells from monocytes |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381628A2 Inflammation-specific peptides and the uses thereof |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381611A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381601A1 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381432A2 Hsa-free formulations of interferon-beta |
| 01/21/2004 | EP1381408A2 Modular infusion device and method |
| 01/21/2004 | EP1381391A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto |
| 01/21/2004 | EP1381390A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 01/21/2004 | EP1381389A1 Smallpox vaccine |
| 01/21/2004 | EP1381382A2 Methods and compositions for the treatment of diseases of the eye |
| 01/21/2004 | EP1381373A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method |
| 01/21/2004 | EP1381372A2 Substituted tetracycline compounds as synergistic antifungal agents |
| 01/21/2004 | EP1381371A2 Hormone replacement therapy |
| 01/21/2004 | EP1381366A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 01/21/2004 | EP1381345A2 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 01/21/2004 | EP1381280A1 Viral vectors and their use in therapeutic methods |
| 01/21/2004 | EP1313749A4 Process for preparation of anhydrous azithromycin |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP1242415B1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 01/21/2004 | EP1126852B1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 01/21/2004 | EP0948491B1 Aminothiazole derivatives useful in the preparation of beta-lactam antibiotics |
| 01/21/2004 | EP0853627B1 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 01/21/2004 | EP0842276B1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv) |
| 01/21/2004 | EP0752871B1 Adhesion inhibiting vaccinium extract |
| 01/21/2004 | EP0727998B1 Oxazoles for treating cytokine mediated diseases |
| 01/21/2004 | CN1469878A Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469868A Use of triazinetrione sulfones for combating coccidiosis |
| 01/21/2004 | CN1469865A Pyrazole derivatives for the treatment of viral diseases |
| 01/21/2004 | CN1469755A Vaccines containing ribavirin and methods of use thereof |
| 01/21/2004 | CN1469754A Orally administered peptides to ameliorate a therosclerosis |
| 01/21/2004 | CN1469752A Method for treating the central nervous system by administration of IGF structural analogs |
| 01/21/2004 | CN1469746A A retroviral immunotherapy |
| 01/21/2004 | CN1469744A Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 01/21/2004 | CN1469742A Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 01/21/2004 | CN1469711A Treatment of helicobacter with isothiocyanates |
| 01/21/2004 | CN1468958A Synthesis and high-efficiency expression method of bivalent foot-and-mouth disease polypeptide vaccine |
| 01/21/2004 | CN1468955A New type of coronavirus |
| 01/21/2004 | CN1468861A Recombinant human immune deficiency virus fusion inhibitor and its prepn and use |
| 01/21/2004 | CN1468629A Chinese medicine composition for treating wind-heat type common cold |
| 01/21/2004 | CN1468620A Medicine for treating acute appendicitis |
| 01/21/2004 | CN1468602A Application of naringin in preparing medicine for supporting treatment of SARS |
| 01/21/2004 | CN1135230C Crystal modification A of 8-cyano-1-cyclopropyl-7-(1S, 6S-2.8-diazabicylo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-chinolincarboxylique |
| 01/21/2004 | CN1135229C Water soluble azoles as broad-spectrum antifungals |
| 01/21/2004 | CN1135111C Anti SARS Chinese herb medicine decoction |
| 01/20/2004 | US6680424 Modified proteinase inhibitors |
| 01/20/2004 | US6680374 Invaplex is a composition of invasin protein(s) (i.e. a protein essential for the bacterium to enter a host cell) and a lipopolysaccharide; use as adjuvant for vaccines, and as diagnostic tool |
| 01/20/2004 | US6680328 Cholinergic ligands of nicotinic acetyl choline receptors for treatment of central nervous system disorders, smooth muscle contraction disorders, endocrine diseases/disorders, neurodegeneration, inflammation, pain, and drug withdrawal |
| 01/20/2004 | US6680318 Piperazinomethylbenzamides as delta-opioid receptor agonists |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/20/2004 | US6680313 1-hydroxyethyl-2(imidazo(5,1b)thiazol-2-yl-1-carbapen-2-em-3-c carboxylic acid or salt, excellent antibiotic activity against a wide spectrum of bacteria |
| 01/20/2004 | US6680308 Administering n-(formyl or acetyl)-n-hydroxylamino)-alkylphosphonic acid derivative as viricide, parasiticide or fungicide |
| 01/20/2004 | US6680303 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith |
| 01/20/2004 | US6680299 Bactericides |
| 01/20/2004 | US6680169 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 01/20/2004 | US6680168 Passive immunization against clostridium difficile disease |
| 01/20/2004 | US6680074 Potent antiviral, antibacterial or antimycotic activity |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | US6680054 Macromolecular neuraminidase-binding compounds |
| 01/20/2004 | CA2243404C Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 01/20/2004 | CA2120751C Trimethoprim oral liquid |
| 01/20/2004 | CA2116782C 1-substituted 1h-imidazo¬4,5-c|quinolin-4-amines; intermediate and pharmaceutical compositions |
| 01/20/2004 | CA2108356C Antibiotic compounds |
| 01/20/2004 | CA2089441C Process for the preparation of cephem prodrug esters |
| 01/15/2004 | WO2004005549A1 Method of estimating effect of interferon |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | WO2004005472A2 Inhibitors of ftsz and uses thereof |
| 01/15/2004 | WO2004005350A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |